As of 2025-09-17, the EV/EBITDA ratio of STAAR Surgical Co (STAA) is -16.15. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STAA's latest enterprise value is 1,172.04 mil USD. STAA's TTM EBITDA according to its financial statements is -72.56 mil USD. Dividing these 2 quantities gives us the above STAA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 11.0x | 9.6x |
| Forward P/E multiples | 10.5x - 17.7x | 13.8x |
| Fair Price | (9.70) - 8.01 | (1.89) |
| Upside | -135.6% - -70.6% | -106.9% |
| Date | EV/EBITDA |
| 2025-09-17 | -16.10 |
| 2025-09-16 | -16.15 |
| 2025-09-15 | -16.45 |
| 2025-09-12 | -16.47 |
| 2025-09-11 | -16.73 |
| 2025-09-10 | -16.44 |
| 2025-09-09 | -16.46 |
| 2025-09-08 | -16.46 |
| 2025-09-05 | -16.63 |
| 2025-09-04 | -16.52 |
| 2025-09-03 | -16.21 |
| 2025-09-02 | -16.50 |
| 2025-08-29 | -16.24 |
| 2025-08-28 | -16.27 |
| 2025-08-27 | -16.34 |
| 2025-08-26 | -16.31 |
| 2025-08-25 | -16.33 |
| 2025-08-22 | -16.57 |
| 2025-08-21 | -16.52 |
| 2025-08-20 | -16.65 |
| 2025-08-19 | -16.65 |
| 2025-08-18 | -16.67 |
| 2025-08-15 | -16.92 |
| 2025-08-14 | -17.06 |
| 2025-08-13 | -16.82 |
| 2025-08-12 | -16.26 |
| 2025-08-11 | -16.20 |
| 2025-08-08 | -16.17 |
| 2025-08-07 | -15.96 |
| 2025-08-06 | -15.93 |
| 2025-08-05 | -16.01 |
| 2025-08-04 | -10.23 |
| 2025-08-01 | -9.73 |
| 2025-07-31 | -9.84 |
| 2025-07-30 | -9.96 |
| 2025-07-29 | -10.29 |
| 2025-07-28 | -10.74 |
| 2025-07-25 | -10.71 |
| 2025-07-24 | -10.56 |
| 2025-07-23 | -10.77 |
| 2025-07-22 | -10.08 |
| 2025-07-21 | -9.73 |
| 2025-07-18 | -9.46 |
| 2025-07-17 | -9.40 |
| 2025-07-16 | -9.28 |
| 2025-07-15 | -9.12 |
| 2025-07-14 | -9.42 |
| 2025-07-11 | -9.48 |
| 2025-07-10 | -9.77 |
| 2025-07-09 | -9.31 |